We are live on ! Find out more
BFM

Boston Financial Management Portfolio holdings

AUM $3.31B
1-Year Est. Return 19.4%
This Fund
S&P 500
This Quarter Est. Return
+4.04%
1 Year Est. Return
+19.4%
3 Year Est. Return
+30.07%
5 Year Est. Return
+107.8%
10 Year Est. Return
+274.5%
AUM
$758M
AUM Growth
+$10.8M
Cap. Flow
-$14.1M
Cap. Flow %
-1.86%
Top 10 Hldgs %
25.76%
Holding
210
New
11
Increased
76
Reduced
102
Closed
7

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.43M
2
V icon
Visa
V
+$1.2M
3
WFM
Whole Foods Market Inc
WFM
+$1.18M
4
RL icon
Ralph Lauren
RL
+$960K
5
CTSH icon
Cognizant
CTSH
+$891K

Top Sells

Rank Stock Value
1
IBM icon
IBM
IBM
+$5.96M
2
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$2.44M
3
XOM icon
ExxonMobil
XOM
+$2.29M
4
ABBV icon
AbbVie
ABBV
+$2.07M
5
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$1.88M

Sector Composition

Rank Sector Weight
1 Healthcare 22.8%
2 Energy 11.9%
3 Industrials 11.23%
4 Consumer Staples 10.78%
5 Technology 9.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UN
151
DELISTED
Unilever NV New York Registry Shares
UN
$697K 0.09%
15,935
-250
-2% -$10.7K
COP icon
152
ConocoPhillips
COP
$145B
$657K 0.09%
7,660
+1,428
+23% +$111K
BNY
153
Bank of New York Mellon
BNY
$107B
$656K 0.09%
17,506
-1,799
-9% -$62.2K
DIS icon
154
Walt Disney
DIS
$167B
$635K 0.08%
7,403
+80
+1% +$6.53K
EOG icon
155
EOG Resources
EOG
$78.1B
$572K 0.08%
4,895
+1,975
+68% +$208K
BRK.A icon
156
Berkshire Hathaway Class A
BRK.A
$1.1T
$570K 0.08%
3
– –
NEM icon
157
Newmont
NEM
$98.3B
$568K 0.07%
22,317
-475
-2% -$11.4K
VEA icon
158
Vanguard FTSE Developed Markets ETF
VEA
$229B
$561K 0.07%
13,180
– –
TBPH icon
159
Theravance Biopharma
TBPH
$874M
$541K 0.07%
+16,982
New +$511K
LOW icon
160
Lowe's Companies
LOW
$117B
$540K 0.07%
11,245
-500
-4% -$23.3K
MO icon
161
Altria Group
MO
$116B
$501K 0.07%
11,948
-3,120
-21% -$126K
HSP
162
DELISTED
HOSPIRA INC
HSP
$471K 0.06%
9,175
+500
+6% +$23.7K
MDY icon
163
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.5B
$470K 0.06%
1,804
-220
-11% -$55.1K
DLTR icon
164
Dollar Tree
DLTR
$24.5B
$469K 0.06%
8,610
-720
-8% -$37.9K
VRSN icon
165
VeriSign
VRSN
$26.2B
$463K 0.06%
+9,480
New +$472K
CMCSK
166
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
$447K 0.06%
8,375
-1
-0% -$53
HON icon
167
Honeywell
HON
$77B
$443K 0.06%
5,307
+144
+3% +$12K
CP icon
168
Canadian Pacific Kansas City
CP
$78.4B
$435K 0.06%
12,000
– –
NBL
169
DELISTED
Noble Energy, Inc.
NBL
$426K 0.06%
5,500
– –
GIS icon
170
General Mills
GIS
$19.3B
$419K 0.06%
7,973
-400
-5% -$21.3K
MDLZ icon
171
Mondelez International
MDLZ
$79.6B
$417K 0.06%
11,088
+1,110
+11% +$40.6K
ESRX
172
DELISTED
Express Scripts Holding Company
ESRX
$399K 0.05%
+5,752
New +$405K
SLV icon
173
iShares Silver Trust
SLV
$27.7B
$391K 0.05%
19,300
– –
EPB
174
DELISTED
EL PASO PIPELINE PARTNERS, L.P. COM UNITS REPSTG LTD PART
EPB
$387K 0.05%
10,675
+400
+4% +$13.4K
QGENF
175
DELISTED
QIAGEN NV
QGENF
$375K 0.05%
15,350
-1,875
-11% -$45.8K
5 6
7
8 9

Similar funds

CANY
Caxton Associates (New York) New York $3.18B AUM 54.49% 1-Year Est. Return
MWM
Merriman Wealth Management Seattle, Washington $2.4B AUM 13.66% 1-Year Est. Return
CCM
Carlson Capital Management Northfield, Minnesota $2.29B AUM 7.48% 1-Year Est. Return
ECG
Edge Capital Group Atlanta, Georgia $2.24B AUM 19.7% 1-Year Est. Return
LSAG
Lake Street Advisors Group Portsmouth, New Hampshire $2.17B AUM 16.99% 1-Year Est. Return
KL
KGH Ltd Nassau, Bahamas $1.92B AUM 13.96% 1-Year Est. Return
WP
WMS Partners Towson, Maryland $1.78B AUM 11.82% 1-Year Est. Return
RDIA
RE Dickinson Investment Advisors Council Bluffs, Iowa $1.77B AUM 15.45% 1-Year Est. Return

Boston Financial Management's Q2 2014 Portfolio in Review

As of Q2 2014, Boston Financial Management held 210 positions worth $758M, up 1.5% from $747M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Boston Financial Management's Q2 2014 filing shows 11 new, 76 increased, 102 reduced and 7 closed positions. Its largest new stake was Theravance Biopharma: 16,982 shares worth $541K. The largest sale was IBM, an estimated $5.96M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 24% a quarter earlier, followed by Energy and Industrials.

  • Boston Financial Management's largest Q2 2014 buy was Theravance Biopharma: 16,982 shares worth $541K.
  • Boston Financial Management added most to Berkshire Hathaway Class B in Q2 2014, an estimated $1.43M increase.
  • Boston Financial Management's biggest Q2 2014 reduction was IBM, cutting an estimated $5.96M.
  • Boston Financial Management fully exited Vanguard Morningstar Total Stock Market ETF in Q2 2014, selling an estimated $1.38M.
  • Boston Financial Management's ten largest holdings make up 26% of its $758M portfolio in Q2 2014.
  • Boston Financial Management opened 11 new positions and closed 7 in Q2 2014.
  • Boston Financial Management's portfolio value rose 1.5% quarter-over-quarter to $758M.

Based on Boston Financial Management's 13F filing for Q2 2014, filed 20 Aug 2014.